Showing results (91-100 of 496) with videos related to
Sort By:
Pageof 50
Journal of Neurochemistry|November 1, 1991
Iron-melanin interaction and lipid peroxidation: implications for Parkinson's diseaseD Ben-Shachar, P Riederer, M B YoudimPsychiatric Genetics|September 20, 2000
Apolipoprotein E genotype in Spanish schizophrenic patientsN Durany, P Riederer, F F Cruz-SánchezJournal of Neural Transmission. Supplementum|January 1, 1994
The enigma of neuromelanin in Parkinson's disease substantia nigraM B Youdim, D Ben-Shachar, P RiedererBrain & Development|January 1, 1987
Reduced concentrations of ascorbic acid and glutathione in a single case of Rett syndrome: a postmortem brain studyE Sofić, P Riederer, W Killian, et al.Neurotoxicity Research|April 24, 2003
Iron in neurodegenerative disordersD. Berg, G. Becker, P. Riederer, et al.Journal of Neural Transmission|January 1, 1981
Transitional states of central serotonin receptors in Parkinson's diseaseE Kienzl, P Riederer, K Jellinger, et al.Journal of Neural Transmission|January 1, 1987
Histochemistry of MAO-A and MAO-B in the locus coeruleus of the Mongolian gerbilC Konradi, K Jellinger, P Riederer, et al.Biological Psychiatry|May 15, 1993
3H-spiroperidol binding to peripheral mononuclear cells in schizophrenic and healthy subjectsN Wodarz, J Fritze, P Riederer, et al.Journal of Neural Transmission. Supplementum|January 1, 1995
The antiparkinsonian drug budipine binds to NMDA and sigma receptors in postmortem human brain tissueJ Kornhuber, B Herr, J Thome, et al.Journal of Neural Transmission. Supplementum|August 30, 2003
Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's diseaseM Gerlach, K Double, H Reichmann, et al.Pageof 50